project id: TCGA-SKCM; case submitter id: TCGA-EE-A2GS; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.84; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.3; rna integrity number: 7.0; age at index: 28; days to birth: -10421; days to death: 2470; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Dead; year of birth: 1978; age at diagnosis: 10421; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage IB; ajcc pathologic t: T2a; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1691.0; icd 10 code: C49.2; last known disease status: not reported; morphology: 8730/3; primary diagnosis: Amelanotic melanoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Connective, subcutaneous and other soft tissues of lower limb and hip; synchronous malignancy: No; tissue or organ of origin: Skin, NOS; tumor grade: Not Reported; year of diagnosis: 2006; alcohol history: Not Reported; is ffpe: false; weight: 20.0; composition: Not Reported; days to collection: 1804; days to sample procurement: 0; initial weight: 110.0; portion submitter id: TCGA-EE-A2GS-06A-12; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 95.0;